---
figid: PMC11983633__fimmu-16-1560706-g006
figtitle: Ribosomal protein L9 is a potential therapeutic target for B-ALL through
  the activation of the p53 signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11983633
filename: fimmu-16-1560706-g006.jpg
figlink: /pmc/articles/PMC11983633/figure/F6/
number: F6
caption: RPL9 is a potential therapeutic target for B-ALL by activating the p53 signaling
  pathway
papertitle: Ribosomal protein L9 is a potential therapeutic target for B-ALL through
  the activation of the p53 signaling pathway
reftext: Xinxin Li, et al. Front Immunol. 2025;16(NA).
year: '2025'
doi: 10.3389/fimmu.2025.1560706
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media SA
keywords: B-ALL | RPL9 | cell proliferation | apoptosis | p53 signaling pathway
automl_pathway: 0.9558788
figid_alias: PMC11983633__F6
figtype: Figure
redirect_from: /figures/PMC11983633__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11983633__fimmu-16-1560706-g006.html
  '@type': Dataset
  description: RPL9 is a potential therapeutic target for B-ALL by activating the
    p53 signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RPL9
  - TP53
  - TP63
  - TP73
  - FTO
  - MICA
  - MICB
---
